Pharmacologic Boosting of Atazanavir in Maintenance HIV-1 Therapy: The COREYA Propensity-Score Adjusted Study

BACKGROUND: Among HIV-1 infected patients who achieved virologic suppression, the use of atazanavir without pharmacologic boosting is debated. We evaluated the efficacy and tolerance of maintenance therapy with unboosted atazanavir in clinical practice. METHODS AND RESULTS: This multicenter retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hocqueloux, Laurent, Choisy, Philippe, Le Moal, Gwenaël, Borsa-Lebas, Françoise, Plainchamp, David, Legac, Eric, Prazuck, Thierry, de la Tribonnière, Xavier, Yazdanpanah, Yazdan, Parienti, Jean-Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494679/
https://www.ncbi.nlm.nih.gov/pubmed/23152890
http://dx.doi.org/10.1371/journal.pone.0049289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494679/
https://www.ncbi.nlm.nih.gov/pubmed/23152890
http://dx.doi.org/10.1371/journal.pone.0049289

Ejemplares similares